ENVERIC BIOSCIENCES, INC. Public Float
ENVERIC BIOSCIENCES, INC. (ENVB) had Public Float of $3.60 million as of 2025-06-30, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-27
- 2025-06-30: Entity Public Float $3.60M.
- 2024-06-30: Entity Public Float $4.90M.
- 2023-06-30: Entity Public Float $7.10M.
- 2022-06-30: Entity Public Float $11.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $3.60M 10-K · filed 2026-03-27 |
| 2024-06-30 | $4.90M 10-K · filed 2025-03-28 |
| 2023-06-30 | $7.10M 10-K · filed 2024-03-26 |
| 2022-06-30 | $11.00M 10-K/A · filed 2023-06-09 |
| 2021-06-30 | $51.00M 10-K · filed 2022-03-31 |
| 2020-06-30 | $7.05M 10-K · filed 2021-04-01 |
| 2019-06-28 | $15.76M 10-K/A · filed 2020-08-12 |
| 2018-06-30 | $11.25M 10-K · filed 2019-03-26 |
| 2017-06-30 | $8.70M 10-K · filed 2018-04-02 |
| 2016-06-30 | $19.98M 10-K/A · filed 2017-04-04 |
| 2015-12-31 | $12.99M 10-KT · filed 2016-03-15 |
| 2014-06-30 | $562.61K 10-K · filed 2015-03-31 |
| 2013-06-30 | $121.42K 10-K · filed 2014-03-28 |
| 2012-06-30 | $100.70K 10-K · filed 2013-02-28 |
| 2012-03-03 | $99.00K 10-K · filed 2012-03-07 |
| 2011-10-31 | $121.42K 10-Q · filed 2011-11-14 |
| 2011-08-01 | $65.00K 10-Q · filed 2011-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |